Who invested in Biocept?
Biocept's investors include Needham Capital Partners.
United States · Funded startup
5 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$17Mraised across 5 rounds since 2006, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $1.2M sold, first sale Feb 2011
No investor was named in the report.
Reported by sec.govSEC filing: $2.3M sold, first sale Aug 2010
No investor was named in the report.
Reported by sec.govSEC filing: $3.6M sold, first sale Mar 2010
No investor was named in the report.
From a historical funding recordSEC filing: $3K sold, first sale Jun 2009
Biocept's investors include Needham Capital Partners.
Biocept has raised $17M across 5 rounds since 2006.
Biocept's most recent round was a Debt of $1.2M in Feb 2011.
Biocept's largest round on record is $10M (Series D), in Jun 2006.
Biocept's first round on record, in Jun 2006, was backed by Needham Capital Partners.
Biocept's latest named round is a Debt, in Feb 2011.
Biocept is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.